Galactaric Acid Biocatalysis with NAD(P)H Oxidase Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing galactaric acid, such as those using gold catalysts or chemical oxidations, are inefficient and costly, and enzymatic methods face challenges with cofactor regeneration and byproduct formation.

Innovation Solution

A biocatalytic process using uronic acid dehydrogenase with NAD(P) as a cofactor, combined with an NAD(P)H oxidase for cofactor regeneration, to oxidize D-galacturonic acid to galactaric acid under mild conditions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If gold catalysts are used for oxidation of D-galacturonic acid, then oxidation productivity is improved, but manufacturing cost increases and catalyst availability decreases

Engineering Contradiction:
Improveoxidation productivityVSAvoidmanufacturing cost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The patent replaces expensive gold catalysts with cost-effective enzymatic systems (dehydrogenase and oxidase enzymes) that can be obtained through biotechnological methods. The enzymatic system achieves comparable oxidation productivity while eliminating the need for precious metal catalysts, directly addressing the cost issue identified in the contradiction.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If chemical oxidation methods are used, then production efficiency is improved, but byproduct formation increases and environmental harm worsens

Engineering Contradiction:
Improveproduction efficiencyVSAvoidbyproduct formation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent substitutes chemical oxidation methods with a biocatalytic system using dehydrogenase and oxidase enzymes. This enzymatic approach maintains high production efficiency while selectively oxidizing D-galacturonic acid to galactaric acid with minimal byproduct formation, eliminating the harmful effects associated with chemical oxidants.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If enzymatic methods are used for oxidation, then selectivity is improved, but cofactor regeneration complexity increases

Engineering Contradiction:
ImproveselectivityVSAvoidcofactor regeneration complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent combines two enzymatic activities (dehydrogenase and oxidase) into a coupled reaction system where the dehydrogenase converts D-galacturonic acid to L-galactonate while regenerating NAD+, and the oxidase simultaneously oxidizes L-galactonate to galactaric acid while consuming NADH. This merging of functions simplifies the overall process by eliminating the need for external cofactor addition or complex regeneration systems.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves high conversion rates and purity of galactaric acid production, with reduced byproduct formation, utilizing cost-effective biodegradable enzymes and mild reaction conditions.

Implementation Method 1

A biocatalytic process using uronic acid dehydrogenase with NAD(P) as a cofactor, combined with an NAD(P)H oxidase for cofactor regeneration, to oxidize D-galacturonic acid to galactaric acid

Methodology Applied
Scientific EffectDehydrogenase catalysis: Enzyme

Implementation Method 2

to oxidize D-galacturonic acid to galactaric acid

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

combined with an NAD(P)H oxidase for cofactor regeneration

Methodology Applied
Scientific EffectOxidase catalysis: Enzyme

Implementation Method 4

NAD(P)H oxidase for cofactor regeneration

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentEP4656731A1Process for producing galactaric acid
Publication Date: 2025.12.03 ANNIKKI GMBH
  • EP4656731A1 patent drawingFigure 1
  • EP4656731A1 patent drawing
  • EP4656731A1 patent drawing

AI summary

A process for the production of galactaric acid, in which galacturonic acid in an aqueous solution is oxidized in vitro with a dehydrogenase with NAD(P)+ as a cofactor to form reduced cofactor NAD(P)H, characterized in that the reduced cofactor NAD(P)H is oxidized with an NAD(P)H oxidase.